Effects of a Specific Substance in Smokers

The purpose of this study is to investigate the neurobiological mechanisms associated with cigarette use in young nondaily smokers (ages 21-25). Nondaily smokers experience fewer symptoms of cigarette withdrawal than daily smokers; however, they still experience difficulty quitting. Since smoking cessation before the age of 30 substantially attenuates the long-term health consequences associated with smoking, understanding the factors that motivate cigarette use in young nondaily smokers and developing tailored interventions will be critical for curbing cigarette use and improving public health. The proposed project will use functional magnetic resonance imaging (fMRI) to examine how other substances (e.g. stimulates, sedatives, or analgesics) impact brain function and will assess the extent to which substance-induced changes in brain function correlate with impulsive choice, cigarette craving, and craving regulation in young adults. Furthermore, the investigators will assess how substance-induced changes in brain function, impulsivity, craving, and capacity for craving regulation predict cigarette use over the course of 1 year.

Inclusion criteria

• Participants must be 21-40 years old
• Right-handed
• Fluent in English
• Report smoking cigarettes or e-cigarettes 1-27 days in the past month
• Report binge drinking based on NIAAA criteria (5 or more drinks per occasion for males, 4 or more drinks per occasion for females) at least 1 time in the past 90 days without adverse incident

Exclusion criteria

• Seeking treatment for substance use (e.g. nicotine or alcohol use)
• Moderate or Severe Nicotine Dependence
• Current alcohol use disorder
• Illicit substance use other than marijuana use in the past year
• Marijuana use more than 10 times in the past year
• Major neurological or medical illness - Significant head trauma - Current use of medication affecting the central nervous system
• MRI contraindications (e.g. irremovable metal on the body or pregnancy)